国产成人精品白浆久久69

In this roundup, 国产成人精品白浆久久69 will catch you up on a few key state advocacy developments and announcements from the past month.

Legal Action Center Releases New Report on Protecting People with SUD From Losing Medicaid Coverage

Last week, the Legal Action Center (LAC) released a report on ‘Protecting People with Substance Use Disorders and Formerly Incarcerated Individuals from Losing Medicaid Coverage.’ This report details key strategies that policymakers can use during the implementation of the “One Big Beautiful Bill Act” to mitigate the potential negative impact on people with SUD. These strategies track closely with a presentation that Deborah Steinberg of LAC delivered to State Advocacy Learning Collaborative Members (SALC) members at a quarterly meeting in late July. As a reminder, SALC is a network of 国产成人精品白浆久久69 state advocates that share policy updates and strategies for success.

Read the LAC report

Join SALC on 国产成人精品白浆久久69 Connect

Proposed Kentucky Buprenorphine Regulation Pulled from Review Committee September Agenda

The Administrative Regulation Review Subcommittee (ARRS) in Kentucky has removed a proposed update for 201 KAR 009:270 from its September agenda while the Kentucky Board of Medical Licensure (KBML) considers adjustments. The Kentucky Society of Addiction Medicine (KYSAM) has led ongoing efforts to push back against this proposed regulation, arguing that it remains a significant barrier to expanding access to buprenorphine treatment in the state. This deferral could be a promising development.

See the updated ARRS Agenda                                                                                                                                           

Virginia Board of Medicine Rejects V国产成人精品白浆久久69 Petition to Amend Buprenorphine Regulations

In August, the Virginia Board of Medicine rejected proposed amendments to its buprenorphine regulations advanced by the Virginia Society of Addiction Medicine (V国产成人精品白浆久久69). The amendments proposed were to remove documentation requirements for buprenorphine doses above 24 mg, remove counseling requirements as a condition of receiving buprenorphine treatment for opioid use disorder (OUD), and allow buprenorphine treatment for OUD to patients younger than 16 on an individualized basis. While this development is disappointing, V国产成人精品白浆久久69 received strong support during the public comment period and will continue to advocate for improved access to buprenorphine treatment for OUD in Virginia.

See V国产成人精品白浆久久69’s petition